Norden Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8M Sell
32,721
-2,298
-7% -$535K 0.77% 23
2025
Q4
$7.25M Buy
35,019
+1,059
+3% +$209K 0.71% 26
2025
Q3
$6.3M Buy
33,960
+3,540
+12% +$606K 0.64% 34
2025
Q2
$4.65M Sell
30,420
-5,366
-15% -$825K 0.5% 44
2025
Q1
$5.93M Buy
35,786
+9,833
+38% +$1.54M 0.68% 23
2024
Q4
$3.75M Buy
25,953
+1,453
+6% +$225K 0.42% 52
2024
Q3
$3.97M Buy
24,500
+12,125
+98% +$1.93M 0.47% 51
2024
Q2
$1.81M Sell
12,375
-1,573
-11% -$234K 0.37% 62
2024
Q1
$2.21M Buy
13,948
+4,897
+54% +$779K 0.45% 52
2023
Q4
$1.42M Sell
9,051
-278
-3% -$42.6K 0.24% 46
2023
Q3
$1.45M Buy
+9,329
New +$1.54M 0.48% 41

Other funds holding JNJ

Norden Group's JNJ Position: Q1 2026 in Review

Norden Group reduced its Johnson & Johnson (JNJ) stake by 6.6% in Q1 2026, selling an estimated $535K and leaving 32,721 shares worth $8M. The position accounts for 0.77% of the portfolio, ranked #23.

Norden Group first reported a position in JNJ in Q3 2023 and has held it in 11 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Norden Group held 32,721 shares of Johnson & Johnson worth $8M as of Q1 2026.
  • Norden Group sold 2,298 Johnson & Johnson shares in Q1 2026, an estimated $535K.
  • Johnson & Johnson made up 0.77% of Norden Group's portfolio in Q1 2026, its #23 holding.
  • Norden Group first reported a position in Johnson & Johnson in Q3 2023 and has held it in 11 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.